Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Arcutis Biotherapeutics (ARQT) Times Interest Earned (2022 - 2025)

Arcutis Biotherapeutics (ARQT) has 4 years of Times Interest Earned data on record, last reported at $6.13 in Q4 2025.

  • For Q4 2025, Times Interest Earned rose 545.63% year-over-year to $6.13; the TTM value through Dec 2025 reached -$1.01, up 78.59%, while the annual FY2025 figure was -$1.01, 78.59% up from the prior year.
  • Times Interest Earned reached $6.13 in Q4 2025 per ARQT's latest filing, up from $2.78 in the prior quarter.
  • Across five years, Times Interest Earned topped out at $6.13 in Q4 2025 and bottomed at -$34.07 in Q1 2022.
  • Average Times Interest Earned over 4 years is -$9.58, with a median of -$7.29 recorded in 2023.
  • The widest YoY moves for Times Interest Earned: up 545.63% in 2025, down 94.57% in 2025.
  • A 4-year view of Times Interest Earned shows it stood at -$9.9 in 2022, then rose by 20.36% to -$7.88 in 2023, then skyrocketed by 82.55% to -$1.37 in 2024, then surged by 545.63% to $6.13 in 2025.
  • Per Business Quant database, its latest 3 readings for Times Interest Earned were $6.13 in Q4 2025, $2.78 in Q3 2025, and -$4.82 in Q2 2025.